Cargando…
Bradycardia in a pediatric population after sugammadex administration: case series
Sugammadex is a distinctive neuromuscular reversal drug that acts by encapsulating the neuromuscular relaxant molecule and dislodging it from its site of action. Sugammadex has been approved for pediatric patients over 2 years of age. Although arrhythmias have been reported, there is no report of ad...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801215/ https://www.ncbi.nlm.nih.gov/pubmed/35121059 http://dx.doi.org/10.1016/j.bjane.2021.12.011 |